BPC-157 for Liver Health
Research, mechanism, dosing, and effectiveness of BPC-157 for liver health.
Quick Answer
BPC-157 has hepatoprotective effects and may support liver regeneration.
Evidence Level
Animal Studies
Typical Dose
250-500 mcg twice daily
Results Timeline
4-8 weeks for liver benefits
FDA Status
Research Only
How BPC-157 Works for Liver Health
Protects liver cells from toxic damage and promotes regeneration.
About Liver Health
Support for liver function and hepatoprotection.
Research Evidence
Extensive preclinical studies demonstrate efficacy in healing tendons, ligaments, muscles, and the GI tract. Only 3 small human pilot studies exist (fewer than 30 total subjects). FDA placed BPC-157 in Category 2 in September 2023, meaning it cannot be used in compounded medications due to insufficient safety data.
Dosing for Liver Health
Recommended Dose
250-500 mcg twice daily
Frequency
1-2x daily
Administration
Subcutaneous injection near injury site, or systemic
Duration
4-12 weeks in most research protocols
Note: Often injected subcutaneously near injury site for localized healing. Systemic administration also common. Many users split into morning and evening doses.
What to Expect
Initial adjustment period. Some users may notice subtle changes.
Early benefits often become noticeable. Continue consistent use.
Most users report meaningful improvements by this point.
Full effects typically realized. Reassess and adjust as needed.
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Generally well-tolerated in preclinical studies
- •Nausea
- •Dizziness
- •Injection site reactions
- •Fatigue
- •Headache
Frequently Asked Questions
Does BPC-157 help with liver health?
BPC-157 has hepatoprotective effects and may support liver regeneration.
How does BPC-157 work for liver health?
Protects liver cells from toxic damage and promotes regeneration....
What dose of BPC-157 should I use for liver health?
250-500 mcg twice daily
How long until I see results?
4-8 weeks for liver benefits
Other Peptides for Liver Health
These peptides are also researched for liver health.
TB-500
PreclinicalA synthetic 17-amino acid fragment of Thymosin Beta-4 (TB-4). Unlike TB-4, TB-500 has a longer half-life (~2-4 days vs ~2 hours) and is the active region responsible for tissue repair and cell migration. Note: Many vendors mislabel TB-4 as 'TB-500' in premixed products.
GHK-Cu
ResearchA naturally occurring copper-binding peptide found in human plasma, saliva, and urine. Widely used in skincare for its wound healing and anti-aging properties.
Pentadecapeptide
PreclinicalThe full 15-amino acid sequence that includes BPC-157. While BPC-157 is more commonly discussed, the full pentadecapeptide has similar healing properties derived from gastric juice.
Thymosin Beta-4
Clinical TrialsThe full 43-amino acid protein that TB-500 is derived from. Naturally occurring in most human tissues, TB-4 has a shorter half-life (~2 hours) compared to its synthetic fragment TB-500 (~2-4 days). Often mislabeled as 'TB-500' by vendors in premixed products.
Educational Information Only
This information about BPC-157 for liver health is for educational purposes only. Always consult with qualified healthcare providers before using any peptide. Individual results may vary.